Showing 14 RESULTS FOR
Depression
Putting Focus on Workplace Mental Health When the Workplace is Home and Home is the Workplace
By Peter Anastasiou
The workplace may look very different than it did a few months ago, but workplace mental health is more important now than ever.
New Study Used Personalized Goals to Assess Treatment Effectiveness for Patients with Major Depressive Disorder
Results from an open-label study evaluating the development and assessment of personalized goals as a way of measuring treatment effectiveness in MDD.
New Data Added to TRINTELLIX® (vortioxetine) Labeling Demonstrated Superiority Over Escitalopram in Improving SSRI-Induced Sexual Dysfunction in Patients with Major Depressive Disorder
TRINTELLIX® is the first antidepressant to include head-to-head data in its labeling that showed improvement in treatment-emergent sexual dysfunction in patients with MDD who switched from certain SSRI treatments.
Video: No Stone Unturned in Mental Health Research
By Doug Williamson, MD
In this video, Dr. Doug Williamson, Lundbeck's Chief Medical Officer and VP of US Medical, discusses putting patients at the center of drug R&D and how Lundbeck is leaving no stone unturned in pursuit of new treatment options.
Video: No Stone Unturned in Mental Health Research
By Doug Williamson, MD
In this video, Dr. Doug Williamson, Lundbeck's Chief Medical Officer and VP of US Medical, discusses putting patients at the center of drug R&D and how Lundbeck is leaving no stone unturned in pursuit of new treatment options.